Characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment

Shwu-Jiuan Sheu,1,2 Ying-Yen Lee,1 Yu-Harn Horng,1 Huey-Shyan Lin,3 Wei-Yu Lai,1 Chui-Lien Tsen1 1Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; 2Department of Ophthalmology, School of Medicine, National Yang-Ming University, Taipei, Taiwan; 3Department of Heal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sheu SJ, Lee YY, Horng YH, Lin HS, Lai WY, Tsen CL
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/a51db4b9a62d48acb71d57bba277532a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a51db4b9a62d48acb71d57bba277532a
record_format dspace
spelling oai:doaj.org-article:a51db4b9a62d48acb71d57bba277532a2021-12-02T08:06:44ZCharacteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment1177-5483https://doaj.org/article/a51db4b9a62d48acb71d57bba277532a2018-09-01T00:00:00Zhttps://www.dovepress.com/characteristics-of-diabetic-macular-edema-on-optical-coherence-tomogra-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Shwu-Jiuan Sheu,1,2 Ying-Yen Lee,1 Yu-Harn Horng,1 Huey-Shyan Lin,3 Wei-Yu Lai,1 Chui-Lien Tsen1 1Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; 2Department of Ophthalmology, School of Medicine, National Yang-Ming University, Taipei, Taiwan; 3Department of Health-Business Administration, Fooyin University, Kaohsiung, Taiwan Purpose: To investigate optical coherence tomography (OCT) characteristics in diabetic macular edema (DME) over time and after treatment. Patients and methods: OCT morphological features in DME eyes treated with ranibizumab with at least 1 year of follow-up were retrospectively analyzed. Results: Thirty-five eyes were included. From baseline to Month 12, mean visual gain was 7.2±13.6 letters and mean central retinal thickness reduction was 61.9±121.8 µm. Fovea-involving ellipsoid zone (EZ) disruption was significantly associated with final vision of <70 letters. Subretinal fluid at baseline was present only in eyes naïve to previous intravitreal pharmacotherapy and was related to better visual gain and fewer injections. Treatment-naïve eyes had shorter DME duration and less EZ damage. Conclusion: DME characteristics on OCT may change over time or after treatment. Subretinal fluid may be associated with earlier change and less EZ damage in DME. Keywords: diabetic macular edema, optical coherence tomography, OCT, subretinal fluid, SRF, vascular endothelial growth factor, VEGFSheu SJLee YYHorng YHLin HSLai WYTsen CLDove Medical Pressarticlediabetic macular edemaOptical Coherence Tomography (OCT)subretinal fluid (SRF)vascular endothelial growth factor (VEGF)OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 1887-1893 (2018)
institution DOAJ
collection DOAJ
language EN
topic diabetic macular edema
Optical Coherence Tomography (OCT)
subretinal fluid (SRF)
vascular endothelial growth factor (VEGF)
Ophthalmology
RE1-994
spellingShingle diabetic macular edema
Optical Coherence Tomography (OCT)
subretinal fluid (SRF)
vascular endothelial growth factor (VEGF)
Ophthalmology
RE1-994
Sheu SJ
Lee YY
Horng YH
Lin HS
Lai WY
Tsen CL
Characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment
description Shwu-Jiuan Sheu,1,2 Ying-Yen Lee,1 Yu-Harn Horng,1 Huey-Shyan Lin,3 Wei-Yu Lai,1 Chui-Lien Tsen1 1Department of Ophthalmology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; 2Department of Ophthalmology, School of Medicine, National Yang-Ming University, Taipei, Taiwan; 3Department of Health-Business Administration, Fooyin University, Kaohsiung, Taiwan Purpose: To investigate optical coherence tomography (OCT) characteristics in diabetic macular edema (DME) over time and after treatment. Patients and methods: OCT morphological features in DME eyes treated with ranibizumab with at least 1 year of follow-up were retrospectively analyzed. Results: Thirty-five eyes were included. From baseline to Month 12, mean visual gain was 7.2±13.6 letters and mean central retinal thickness reduction was 61.9±121.8 µm. Fovea-involving ellipsoid zone (EZ) disruption was significantly associated with final vision of <70 letters. Subretinal fluid at baseline was present only in eyes naïve to previous intravitreal pharmacotherapy and was related to better visual gain and fewer injections. Treatment-naïve eyes had shorter DME duration and less EZ damage. Conclusion: DME characteristics on OCT may change over time or after treatment. Subretinal fluid may be associated with earlier change and less EZ damage in DME. Keywords: diabetic macular edema, optical coherence tomography, OCT, subretinal fluid, SRF, vascular endothelial growth factor, VEGF
format article
author Sheu SJ
Lee YY
Horng YH
Lin HS
Lai WY
Tsen CL
author_facet Sheu SJ
Lee YY
Horng YH
Lin HS
Lai WY
Tsen CL
author_sort Sheu SJ
title Characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment
title_short Characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment
title_full Characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment
title_fullStr Characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment
title_full_unstemmed Characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment
title_sort characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/a51db4b9a62d48acb71d57bba277532a
work_keys_str_mv AT sheusj characteristicsofdiabeticmacularedemaonopticalcoherencetomographymaychangeovertimeoraftertreatment
AT leeyy characteristicsofdiabeticmacularedemaonopticalcoherencetomographymaychangeovertimeoraftertreatment
AT horngyh characteristicsofdiabeticmacularedemaonopticalcoherencetomographymaychangeovertimeoraftertreatment
AT linhs characteristicsofdiabeticmacularedemaonopticalcoherencetomographymaychangeovertimeoraftertreatment
AT laiwy characteristicsofdiabeticmacularedemaonopticalcoherencetomographymaychangeovertimeoraftertreatment
AT tsencl characteristicsofdiabeticmacularedemaonopticalcoherencetomographymaychangeovertimeoraftertreatment
_version_ 1718398677428469760